Differential twin concordance for multiple sclerosis by latitude of birthplace

Annals of Neurology

Volumn 60, Issue 1, 2006, Pages 56-64

  Islam, Talat ^a   Gauderman, W James ^a   Cozen, Wendy ^a   Hamilton, Ann S ^a   Burnett, Margaret E ^a   Mack, Thomas M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIRTHPLACE; CANADA; CHILD; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; HEREDITY; HUMAN; LATITUDE; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; QUESTIONNAIRE; TWIN CONCORDANCE; UNITED STATES; ZYGOSITY;

ADULT; AGE OF ONSET; CANADA; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; RISK FACTORS; SEX DISTRIBUTION; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; UNITED STATES;

EID: 33745728408     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20871     Document Type: Article

References (43)

1. Kurtzke JF. Geography in multiple sclerosis. J Neurol 1977;215:1-26.
2. Hammond SR, McLeod JG, Millingen K, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle, and Hobart. Brain 1988;111(pt 1):1-25.
3. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:565-568.
4. Levin LI, Munger KL, Rubertone MV, et al. Multiple sclerosis and Epstein-Barr virus. JAMA 2003;289:1533-1536.
5. van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316.
6. Dean G, Bhigjee AI, Bill PL, et al. Multiple sclerosis in black South Africans and Zimbabweans. J Neurol Neurosurg Psychiatry 1994;57:1064-1069.
7. Ebers GC, Sadovnick AD. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 1993;12:1-5.
8. Nielsen N, Westergaard T, Rostgaard K, et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol 2005;162:1-5.
9. Sadovnick AD, Dircks A, Ebers GC. Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals. Clin Genet 1999;56:118-122.
10. Robertson NP, Fraser M, Deans J, et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996;119(pt 2):449-455.
11. Barcellos LF, Oksenberg JR, Begovich AB, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003;72:710-716.
12. Sadovnick AD, Armstrong H, Rice GP, et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993;33:281-285.
13. Mumford CJ, Wood NW, Kellar-Wood H, et al. The British Isles survey of multiple sclerosis in twins. Neurology 1994;44:11-15.
14. Willer CJ, Ebers GC. Susceptibility to multiple sclerosis: interplay between genes and environment. Curr Opin Neurol 2000;13:241-247.
15. Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. French Research Group on Multiple Sclerosis. Ann Neurol 1992;32:724-727.
16. Ristori G, Salvetti M, Canonni S, et al. A nationwide study of multiple sclerosis in Italian twins. Twin Res 2004;7:375.
17. Wilier CJ, Dyment DA, Risch NJ, et al. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 2003;100:12877-12882.
18. Mack TM, Deapen D, Hamilton AS. Representativeness of a roster of volunteer North American twins with chronic disease. Twin Res 2000;3:33-42.
19. Hernan MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999;53:1711-1718.
20. Torgersen S. The determination of twin zygosity by means of a mailed questionnaire. Acta Genet Med Gemellol (Roma) 1979;28:225-236.
21. Deapen D, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992;35:311-318.
22. Kumar D, Gemayel NS, Deapen D, et al. North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 1993;42:1351-1363.
23. Cozen W, Gill PS, Ingles SA, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood 2004;103:3216-3221.
24. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on evaluation of experimental trials therapy in multiple sclerosis. Ann N Y Acad Sci 1965;122:552-568.
25. Sadovnick A, Ebers G. Epidemiology of multiple sclerosis: a critical overview. J Can Sci Neurol 1993;20:17-29.
26. Sloka JS, Pryse-Phillips WE, Stefanelli M. Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador. Can J Neurol Sci 2005;32:37-42.
27. Allen G, Parisi P. Trends in monozygotic and dizygotic twinning rates by maternal age and parity. Further analysis of Italian data, 1949-1985, and rediscussion of US data, 1964-1985. Acta Genet Med Gemellol (Roma) 1990;39:317-328.
28. Sweeney VP, Sadovnick AD, Brandejs V. Prevalence of multiple sclerosis in British Columbia. Can J Neurol Sci 1986;13:47-51.
29. Vogel F, Motulsky A. Human genetics: problems and approaches. New York: Springer, 1997.
30. Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in U.S. veterans: 1. race, sex, and geographic distribution. Neurology 1979;29:1228-1235.
31. Visscher B, Detels R, Coulson A, et al. Latitude, migration, and the prevalence of multiple sclerosis. Am J Epidemiol 1977;106:470-475.
32. Wallin MT, Page WF, Kurtzke JF. Epidemiology of multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex and geography. Ann Neurol 2004;55:65-71.
33. Heltberg A, Holm N. Concordance in twins and recurrence in sibships in multiple sclerosis. Lancet 1982;1:1068.
34. Kinnunen E, Juntunen J, Ketonen L, et al. Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series. Arch Neurol 1988;45:1108-1111.
35. Ebers GC, Sadovnick AD, Dyment DA, et al. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 2004;363:1773-1774.
36. Sadovnick AD, Yee IM, Ebers GC, Risch NJ. Effect of age at onset and parental disease status on sibling risks for MS. Neurology 1998;50:719-723.
37. Hensiek AE, Sawcer SJ, Feakes R, et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;72:184-187.
38. Masterman T, Hillert J. HLA-DR15 and age at onset in multiple sclerosis. Eur J Neurol 2002;9:179-180.
39. Barcellos LF, Schito AM, Rimmler JB, et al. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 2000;51:281-288.
40. Kurtzke JF, Page WF, Murphy FM, Norman JE Jr. Epidemiology of multiple sclerosis in US veterans. 4. Age at onset. Neuroepidemiology 1992;11:226-235.
41. Ponsonby AL, van der Mei I, Dwyer T, et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 2005;293:463-469.
42. Mack TM, Hamilton AS, Press MF, et al. Heritable breast cancer in twins. Br J Cancer 2002;87:294-300.
43. Hamilton AS, Mack TM. Puberty and genetic susceptibility to breast cancer in a case-control study in twins. N Engl J Med 2003;348:2313-2322.